Northwestern Mutual Wealth Management
KROS icon

Northwestern Mutual Wealth Management’s Keros Therapeutics KROS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46
Closed -$937 – 4321
2025
Q4 		$937 Buy
+46
New +$807 ﹤0.01% 3646
2025
Q2 		– Sell
-17,674
Closed -$180K – 3847
2025
Q1 		$180K Hold
17,674
– – ﹤0.01% 1709
2024
Q4 		$280K Hold
17,674
– – ﹤0.01% 1519
2024
Q3 		$1.03M Buy
+17,674
New +$873K ﹤0.01% 1054

Other funds holding KROS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Northwestern Mutual Wealth Management's KROS Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Keros Therapeutics (KROS) in Q1 2026, closing a stake of 46 shares — an estimated $937 sold.

Northwestern Mutual Wealth Management first reported a position in KROS in Q3 2024 and held it in 4 quarters. The position peaked at $1.03M in Q3 2024. 151 funds tracked by Wall St. Rank hold KROS as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Keros Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 46 Keros Therapeutics shares in Q1 2026, an estimated $937.
  • Northwestern Mutual Wealth Management first reported a position in Keros Therapeutics in Q3 2024 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Keros Therapeutics position peaked at $1.03M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.